Dicranopteris linearisA potential medicinal plant with anticancer properties

Abstract

Several investigations have demonstrated Dicranopteris linearis(Burm.f.) Underw. (Gleicheniaceae) plant extracts possess numerous health-promoting properties. This review is aimed to summarize and highlight the potential possess by D. linearisto be developed into future pharmacological entity especially as anticancer agent. This study used several electronic search engines to compile and integrate a number of scientific publications related with D. linearis. Scientifically, D. linearishas been reported to have antinociceptive, anti-inflammatory, antipyretic, chemopreventive and antioxidant properties which can be linked to its potential to treat various kinds of ailments including inflammatory-relateddiseases and cancer. A number of scientific evidences related with anticancer studies suggested the ability of D. linearis-based phytochemicals to act as potent anticancer lead compounds. In conclusion, D. linearishas the potential to be developed into potent anticancer agent as depicted by a number of isolated phytochemicals which can work synergistically to contribute to its anticancer properties.

Magnetic/Zeolitic Imidazolate Framework-67 Nanocomposite for Magnetic Solid-Phase Extraction of Five Flavonoid Components from Chinese Herb Dicranopteris pedata

“…Nakai is a perennial herb found in Dicranopteris Bernh, which belongs to the Gleicheniaceae family. Dicranopteris pedata is rich in flavonoids, saponins, and polysaccharides; exhibits strong antioxidant, antibacterial, and anticancer pharmacological properties; and has attracted considerable attention in the biomedical field [ 1 , 2 , 3 , 4 ]. To date, flavonoids in Dicranopteris pedata have been isolated and analyzed using high-performance liquid chromatography–ultraviolet detection (HPLC-UV) [ 5 ] and ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-Q- TOF/MS) [ 6 ].…”